These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Matrix bound SFD mutant TIMP-3 is more stable than wild type TIMP-3. Majid MA; Smith VA; Newby AC; Dick AD Br J Ophthalmol; 2007 Aug; 91(8):1073-6. PubMed ID: 17383996 [TBL] [Abstract][Full Text] [Related]
12. A second independent Tyr168Cys mutation in the tissue inhibitor of metalloproteinases-3 (TIMP3) in Sorsby's fundus dystrophy. Felbor U; Stöhr H; Amann T; Schönherr U; Apfelstedt-Sylla E; Weber BH J Med Genet; 1996 Mar; 33(3):233-6. PubMed ID: 8728699 [TBL] [Abstract][Full Text] [Related]
13. Tissue Inhibitor of Metalloproteinase 3 (TIMP3) mutations increase glycolytic activity and dysregulate glutamine metabolism in RPE cells. Grenell A; Singh C; Raju M; Wolk A; Dalvi S; Jang GF; Crabb JS; Hershberger CE; Manian KV; Hernandez K; Crabb JW; Singh R; Du J; Anand-Apte B Mol Metab; 2024 Oct; 88():101995. PubMed ID: 39047907 [TBL] [Abstract][Full Text] [Related]
14. Tissue inhibitor of metalloproteinase-3 differentially binds to components of Bruch's membrane. Majid MA; Smith VA; Matthews FJ; Newby AC; Dick AD Br J Ophthalmol; 2006 Oct; 90(10):1310-5. PubMed ID: 16837541 [TBL] [Abstract][Full Text] [Related]
15. Sorsby's fundus dystrophy in a family with a Ser-181-CVS mutation in the TIMP-3 gene: poor outcome after laser photocoagulation. Sieving PA; Boskovich S; Bingham E; Pawar H Trans Am Ophthalmol Soc; 1996; 94():275-94; discussion 295-7. PubMed ID: 8981701 [TBL] [Abstract][Full Text] [Related]
16. TIMP-3 mRNA is not overexpressed in Sorsby fundus dystrophy. Chong NH; Kvanta A; Seregard S; Bird AC; Luthert PJ; Steen B Am J Ophthalmol; 2003 Nov; 136(5):954-5. PubMed ID: 14597066 [TBL] [Abstract][Full Text] [Related]
17. Sorsby fundus dystrophy - A review of pathology and disease mechanisms. Christensen DRG; Brown FE; Cree AJ; Ratnayaka JA; Lotery AJ Exp Eye Res; 2017 Dec; 165():35-46. PubMed ID: 28847738 [TBL] [Abstract][Full Text] [Related]
18. In vitro stem cell modelling demonstrates a proof-of-concept for excess functional mutant TIMP3 as the cause of Sorsby fundus dystrophy. Hongisto H; Dewing JM; Christensen DR; Scott J; Cree AJ; Nättinen J; Määttä J; Jylhä A; Aapola U; Uusitalo H; Kaarniranta K; Ratnayaka JA; Skottman H; Lotery AJ J Pathol; 2020 Oct; 252(2):138-150. PubMed ID: 32666594 [TBL] [Abstract][Full Text] [Related]
19. Localization of the functional domains of human tissue inhibitor of metalloproteinases-3 and the effects of a Sorsby's fundus dystrophy mutation. Langton KP; Barker MD; McKie N J Biol Chem; 1998 Jul; 273(27):16778-81. PubMed ID: 9642234 [TBL] [Abstract][Full Text] [Related]
20. Night blindness in Sorsby's fundus dystrophy reversed by vitamin A. Jacobson SG; Cideciyan AV; Regunath G; Rodriguez FJ; Vandenburgh K; Sheffield VC; Stone EM Nat Genet; 1995 Sep; 11(1):27-32. PubMed ID: 7550309 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]